Exercise as a Therapeutic Intervention in Patients with Stable Ischemic Heart Disease: An Underfilled Prescription

被引:15
|
作者
Boden, William E. [1 ,2 ]
Franklin, Barry [3 ,4 ]
Berra, Kathy [5 ]
Haskell, William L. [6 ]
Calfas, Karen J. [7 ]
Zimmerman, Franklin H. [8 ]
Wenger, Nanette K. [9 ]
机构
[1] Samuel S Stratton VA Med Ctr, Albany, NY USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] William Beaumont Hosp, Royal Oak, MI 48072 USA
[4] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA
[5] LifeCare Co, Menlo Pk, CA USA
[6] Stanford Univ, Palo Alto, CA 94304 USA
[7] Univ Calif San Diego, La Jolla, CA 92093 USA
[8] Phelps Mem Hosp Ctr, Sleepy Hollow, NY USA
[9] Emory Univ, Sch Med, Atlanta, GA USA
来源
AMERICAN JOURNAL OF MEDICINE | 2014年 / 127卷 / 10期
关键词
Exercise; Secondary prevention; Stable ischemic heart disease; QUALITY-OF-LIFE; ASSOCIATION TASK-FORCE; CARDIAC REHABILITATION; PHYSICAL-ACTIVITY; SECONDARY PREVENTION; CLINICAL-CARDIOLOGY; FUNCTIONAL-CAPACITY; AMERICAN-COLLEGE; SUBLINGUAL NITROGLYCERIN; CARDIOVASCULAR-DISEASE;
D O I
10.1016/j.amjmed.2014.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment for stable ischemic heart disease may include guideline-directed pharmacologic therapy, coronary revascularization, and lifestyle and behavioral changes, including structured exercise. Of these, regular exercise is arguably one of the most cost-effective yet underused interventions. Most patients with stable ischemic heart disease are eligible for secondary prevention programs, which should include exercise training regimens, but participation in such programs remains suboptimal. This review emphasizes the importance of education for both patients and providers to enhance participation in lifestyle physical activity, structured exercise, or both. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:905 / 911
页数:7
相关论文
共 50 条
  • [31] Myocardial bioenergetic profiling in patients with stable ischemic heart disease
    Jones, Richard E.
    Prasad, Sanjay K.
    [J]. NATURE CARDIOVASCULAR RESEARCH, 2023, 2 (08): : 716 - 717
  • [32] Should patients with stable ischemic heart disease undergo revascularization?
    Chenier, Michael
    Lincoff, A. Michael
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2016, 83 (08) : 567 - 570
  • [33] Hemodynamic effects of sildenafil in patients with stable ischemic heart disease
    Manfroi, WC
    Caramori, PRA
    Zago, AJ
    Melchior, R
    Zen, V
    Accordi, M
    Gutierres, D
    Noer, C
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 90 (2-3) : 153 - 157
  • [34] CARDIOREHABILITATION OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE: COMPLIANCE WITH TREATMENT
    Svet, A. V.
    Doletsky, A. A.
    Chaplygin, A. V.
    Syrkin, A. L.
    [J]. TERAPEVTICHESKII ARKHIV, 2008, 80 (09): : 52 - 57
  • [35] Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease
    Joseph Walker Keach
    Robert W. Yeh
    Thomas M. Maddox
    [J]. Current Atherosclerosis Reports, 2016, 18
  • [36] Myocardial bioenergetic profiling in patients with stable ischemic heart disease
    [J]. Nature Cardiovascular Research, 2023, 2 : 716 - 717
  • [37] Novel approaches to the management of patients with stable ischemic heart disease
    Oganov, RG
    Pozdnyakov, YM
    Karpov, YA
    [J]. KARDIOLOGIYA, 2004, 44 (10) : 95 - 101
  • [38] Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease
    Keach, Joseph Walker
    Yeh, Robert W.
    Maddox, Thomas M.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (01)
  • [39] Fluctuating inflammatory markers in patients with stable ischemic heart disease
    Bogaty, P
    Brophy, MM
    Boyer, L
    Simard, S
    Joseph, L
    Bertrand, F
    Dagenais, GR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) : 221 - 226
  • [40] Aerobic exercise: a potential therapeutic intervention for patients with liver disease
    Bergasa, NV
    Mehlman, J
    Bir, K
    [J]. MEDICAL HYPOTHESES, 2004, 62 (06) : 935 - 941